Level Brands, Inc. (NYSE:LEVB)
Level Brands, Inc. (NYSE:LEVB) represented a move of 0 percent or $0.78 per share and closed its previous day trading session at $4.07. 0 Shares were traded in the last trading session with an Average Volume of 534.99 Million Shares. The stock currently has a Market Capitalization of 36.18 Million.
Level Brands, Inc. operates as a branding and marketing company. It focuses on consumer products such as marketing beauty, fashion and entertainment. Level Brands, Inc. is based in Charlotte, United States.
The stock traded between $2.74 and $8.48 over 1-Year time period showing its price to sales ratio of 4.52. Level Brands, Inc. (NYSE:LEVB) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-3.02 and 200-Day Simple Moving Average of $0.17. Its Price to Free Cash Flow is 0 and Price to Book of 2.38.
Analyst’s recommended the stock as 0 where 1 represents Strong Buy and 5 represents Sell.
Achieve Life Sciences, Inc. (NASDAQ:ACHV)
In the last trading session, Achieve Life Sciences, Inc. (NASDAQ:ACHV) added its value by 0% closing at the price of $1.48. The stock currently has market capitalization of 10.12 Million, with average volume of 1.1 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Achieve Life Sciences, Inc. (NASDAQ:ACHV) is showing beta of 2.19. This particular value of beta suggests that Achieve Life Sciences, Inc. (NASDAQ:ACHV) has historically moved 219% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Achieve Life Sciences, Inc. (NASDAQ:ACHV) is at $-8.12.
The stock currently has RSI of 27.9. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Achieve Life Sciences Inc. is a pharmaceutical company. It develops and commercializes cytisine treatment to help people battling nicotine addiction. The Company’s product candidates include Custirsen, Apatorsen and OGX-225. Achieve Life Sciences Inc., formerly known as OncoGenex Pharmaceuticals Inc., is based in Bothell, United States.
Achieve Life Sciences, Inc. (NASDAQ:ACHV) topped its 52-week high price of $32.00 on 01/24/18 and 52-Week Low Price of $ 1.46 on 12/04/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 7.79% and monthly volatility of 8.27% respectively.